Carna Biosciences, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Contract Research Organization-CRO
  • Biotechnology
    • Drug Discovery Technologies
  • Services

Other Names/Subsidiaries

  • CarnaBio USA
See more in Biomedtracker

Latest on Carna Biosciences, Inc.

Scrip

Deal Watch: Amgen Taps Plexium's Expertise In Targeted Protein Degradation

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Amgen, Plexium Team Up Against Challeng

Scrip

Asia Deal Watch: Oxford Biomedica’s First Japanese Partnership Focuses On Rare Retinal Disorder

 
• By Ian Haydock, Brian Yang, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Santen, Oxford Biomedica Col

Scrip

Deal Watch: Gilead Partners With Carna On Small Molecule IO Drug Development

 
• By Joseph Haas, Eleanor Malone, Alex Shimmings, and Jo Shorthouse

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . $470m Gilead/Carna Alliance

Scrip

UK Charity Starts Early-Stage Clinical Studies Of Lilly's Cdc7 Inhibitor

 
• By John Davis

The Centre for Drug Development of the UK’s leading cancer charity, Cancer Research UK , announced Aug. 23 it will start testing a novel type of anticancer from Eli Lilly & Co. under its partner